Follow the Hemostemix Inc. stock price and the full management transaction log of the company, a listed issuer based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €14.3m. The latest transaction was reported on 10 August 2026 (11 - Acquisition or disposition carried out privately). Among the most active insiders: Swanberg, Loran Lavern. The full history is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Hemostemix Inc. is a Toronto Stock Exchange listed company focused on developing regenerative therapies for cardiovascular diseases. It utilizes stem cell-based technologies to enhance patient health.